SBC Medical Group
SBC | NASDAQ
$5.14
+$0.39 (+8.21%)
At close: Sep 21, 2026, 4:00 PM ET
$5.24
+$0.10 (+1.95%)
Pre-market:
Sep 22, 2026, 4:43 AM ET
Company Profile
SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other international markets. The company delivers a diverse array of administrative and support functions, such as orchestrating marketing and advertising campaigns, offering extensive human resources solutions including talent acquisition and staff training, and streamlining appointment scheduling for franchisee clinics. Furthermore, SBC Medical Group facilitates real estate arrangements for both employee housing and clinic facility rentals, oversees the design and construction of new clinics, and manages the procurement of essential medical equipment and supplies. Additionally, the firm furnishes IT software solutions. The broad spectrum of aesthetic and reconstructive procedures facilitated by SBC Medical Group's supported clinics encompasses both surgical and non-surgical interventions. These include popular treatments such as breast augmentation, liposuction, and various rejuvenation therapies targeting wrinkles, acne, scars, and signs of aging. The offerings also extend to specialized procedures like laser skin toning, double fold eye surgery, rhinoplasty, hair transplants, laser hair removal, cosmetic dental work, tattoo removal, and advanced eye procedures like LASIK, among others. Established in 2000, SBC Medical Group Holdings Incorporated maintains its headquarters in Irvine, California.
Key Executives
| Name | Position |
|---|---|
| Yoshiyuki Aikawa | Chairman & Chief Executive Officer |
| Hiroyuki Miya | Chief Operating Officer of SBC Medical Group Co., Ltd. (Japan) |
| Shengfu Hsiao | Chief Technology Officer |
| Shinya Inoue | Chief Marketing Officer |
| Yuya Yoshida | Chief Operating Officer, Chief Financial Officer & Director |
| Akiko Wakiyama | Chief Public Relations Officer |
| Hikaru Fukui | Head of IR & CHRO of SBC Medical Group Co., Ltd. (Japan) |
| Kazuki Ichimori | Chief Corporate Development Officer |
| Miki Yamazaki | Chief Strategy Officer |
| Ryoji Murata | Principal Accounting Officer |
| Taiki Sakaguchi | CHRO, Chief Planning Officer & Corporate Secretary |
| Yoshimune Tanaka | Property Acquisition Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 13, 2026 | 10-Q | Quarterly Report |
| Aug 13, 2026 | 8-K | Current Report |
| Jul 14, 2026 | 8-K | Current Report |
| May 28, 2026 | ARS | Filing |
| May 28, 2026 | DEFA14A | Filing |
| May 28, 2026 | DEF 14A | Filing |
| May 20, 2026 | 8-K | Current Report |
| May 15, 2026 | PRE 14A | Filing |
| May 14, 2026 | 10-Q | Quarterly Report |
| May 14, 2026 | 8-K | Current Report |
SBC Medical Group
| Country | United States |
| IPO Date | Sep 25, 2022 |
| Industry | Consulting Services |
| Sector | Industrials |
| Employees | 863 |
| CEO | Yoshiyuki Aikawa |
Contact Details
200 Spectrum Center Drive Irvine,
California 92618 United States
Stock Details
| Ticker Symbol | SBC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001930313 |
| CUSIP Number | 73245B107 |
| ISIN Number | US73245B1070 |
| SIC Code | 8011 |
Add to Watchlist
Select watchlists to add or remove SBC